Apexian Pharmaceuticals Hires Richard Messmann, M.D. as Chief Medical Officer

Indianapolis, IN – October 31, 2016 – Apexian Pharmaceutical, Inc., a clinical stage biotechnology company focused on developing novel compounds to treat cancer, today announced the hiring of Richard Messmann, M.D. as Chief Medical Officer (CMO) of the company. “We are extremely pleased to have Rich become our CMO at Apexian Pharmaceuticals,” said Steve Carchedi, CEO for the company. “Rich is a proven clinical scientist … Read more…

Dr. Mark Kelley featured in BioCrossroads “Money, Molecules and Management” publication

Apexian’s Dr. Mark Kelley is one of 12 profiles featured in the BioCrossroads new white paper, “Powering Indiana’s Life Sciences Community: Profiles of Money, Molecules and Management”. The profiles are of people critical to the development of Indiana’s life sciences include the people who mind the money, the molecules and the management necessary to nurture the state’s important economic sector. To understand what powers Indiana’s … Read more…